Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:29:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the 403 error for the study record. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:14:37.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page now displays revision v3.7.1 instead of v3.7.0. The study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-07T00:26:55.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record content. The new page shows a minimal header with a Home link, indicating restricted access to the record rather than substantive study information.
    Difference
    20%
    Check dated 2026-09-23T00:22:47.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a newer version of the page template or CMS. No study-related content is altered.
    Difference
    0.0%
    Check dated 2026-09-15T23:50:00.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, indicating a small update to the study record without altering displayed content.
    Difference
    0.0%
    Check dated 2026-09-01T20:00:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.